论文部分内容阅读
目的:了解女性冠心病患者在接受冠状动脉介入治疗(PCI)后的长期临床疗效。方法:584例经PCI治疗的患者,被分为女性组(122例)和男性组(462例),收集其一般临床资料及PCI治疗情况,并进行长期(3~49个月)临床随访,详细记录患者临床主要不良事件的发生情况。结果:男性患者的全因性死亡率(0∶3.03%,P>0.05)及心因性死亡率(0∶2.98%,P>0.05)有增高趋势,女性患者因心脏病再住院率(15.57%∶9.96%,P<0.05)显著增加,但2组患者其他临床主要不良事件差异无统计学意义。经过校正不匹配因素的偏相关分析显示,男性与心因性死亡(r=0.0874,P<0.05)及全因性死亡(r=0.0970,P<0.05)呈正相关。结论:女性患者PCI治疗的长期临床预后良好。
Objective: To understand the long-term clinical efficacy of female patients with coronary artery disease undergoing coronary intervention (PCI). Methods: 584 PCI patients were divided into female group (122 cases) and male group (462 cases). The clinical data and PCI were collected and followed up for a long time (range 3 to 49 months) Detailed records of patients with clinical occurrence of major adverse events. Results: All-cause mortality (0: 3. 03%, P> 0.05) and cardiac mortality (0: 2.98%, P> 0.05) in male patients increased with the rate of rehospitalization %: 9.96%, P <0.05), but there was no significant difference in other clinical major adverse events between the two groups. Partial correlation analysis of adjusted mismatch factors showed a positive correlation between males and cardiac death (r = 0.0874, P <0.05) and all-cause mortality (r = 0.0970, P <0.05). Conclusion: The long-term clinical prognosis of female patients with PCI is good.